Quick Answer
SkinHealth Systems Inc. reported Total Revenue of $300.79 million for fiscal year 2025.
SkinHealth Systems Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $300.79M -10.0% |
$334.29M -16.0% |
$397.99M +8.8% |
$365.88M +40.7% |
$260.09M +118.4% |
$119.09M -28.5% |
| Revenue (ASC 606) | $300.79M -10.0% |
$334.29M -16.0% |
$397.99M +8.8% |
$365.88M +40.7% |
$260.09M +118.4% |
$119.09M -28.5% |
| Net Income | -$9.52M +67.3% |
-$29.10M +70.9% |
-$100.12M -326.4% |
$44.22M +111.7% |
-$378.76M -1198.2% |
-$29.18M -1681.1% |
| Diluted EPS | -$0.16 +55.6% |
-$0.36 +52.6% |
-$0.76 -230.4% |
-$0.23 +93.8% |
-$3.71 -336.5% |
-$0.85 -1600.0% |
| Total Assets | $499.80M -27.1% |
$685.68M -26.2% |
$929.11M -7.4% |
$1.00B -17.7% |
$1.22B +447.0% |
$222.84M |
| Cash and Equivalents | — | — | $523.02M -8.0% |
$568.20M -37.0% |
$901.89M +9407.5% |
$9.49M |
| Stockholders Equity | $61.06M +17.9% |
$51.80M -12.8% |
$59.39M -64.4% |
$167.05M -43.9% |
$298.03M +1075.0% |
-$30.57M -2430.4% |
| R&D Expense | $5.63M -10.6% |
$6.30M -37.7% |
$10.10M +19.6% |
$8.44M +3.0% |
$8.20M +140.4% |
$3.41M -26.1% |
| Operating Income | -$20.80M +69.3% |
-$67.77M +48.2% |
-$130.92M -406.6% |
-$25.84M +35.3% |
-$39.93M -132.4% |
-$17.18M -227.6% |
| Gross Profit | $196.36M +7.7% |
$182.30M +17.5% |
$155.11M -37.7% |
$248.78M +39.3% |
$178.54M +165.7% |
$67.20M -36.9% |
| Shares Outstanding | 127.52M +2.1% |
124.92M +1.6% |
122.90M -7.0% |
132.21M +243129.5% |
54,358 -99.8% |
35.50M +10.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $70.66M | -10.3% | -9.6% |
| Revenue (ASC 606) | September 30, 2025 | $70.66M | -10.3% | -9.6% |
| Net Income | September 30, 2025 | -$11.03M | +39.7% | -156.0% |
| Diluted EPS | September 30, 2025 | -$0.09 | +40.0% | -400.0% |
| Total Assets | September 30, 2025 | $503.64M | -28.0% | -0.8% |
| Cash and Equivalents | September 30, 2023 | $559.44M | -18.2% | +1.8% |
| Stockholders Equity | September 30, 2025 | $65.66M | +9.9% | -11.3% |
| R&D Expense | September 30, 2025 | $1.70M | +53.2% | +35.7% |
| Operating Income | September 30, 2025 | -$6.24M | +71.0% | -131.2% |
| Gross Profit | September 30, 2025 | $45.63M | +12.3% | -7.1% |
| Shares Outstanding | September 30, 2025 | 127.30M | +2.6% | +0.4% |
- SkinHealth Systems Inc. reported Total Revenue of $300.79 million for fiscal year 2025.
- SkinHealth Systems Inc. showed a decrease of -10.0% in Total Revenue compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Revenue (ASC 606) of $300.79 million for fiscal year 2025.
- SkinHealth Systems Inc. showed a decrease of -10.0% in Revenue (ASC 606) compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Net Income of -$9.52 million for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +67.3% in Net Income compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +55.6% in Diluted EPS compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Total Assets of $499.80 million for fiscal year 2025.
- SkinHealth Systems Inc. showed a decrease of -27.1% in Total Assets compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Cash and Equivalents of $523.02 million for fiscal year 2023.
- SkinHealth Systems Inc. showed a decrease of -8.0% in Cash and Equivalents compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Stockholders Equity of $61.06 million for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +17.9% in Stockholders Equity compared to the prior fiscal year.
- SkinHealth Systems Inc. reported R&D Expense of $5.63 million for fiscal year 2025.
- SkinHealth Systems Inc. showed a decrease of -10.6% in R&D Expense compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Operating Income of -$20.80 million for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +69.3% in Operating Income compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Gross Profit of $196.36 million for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +7.7% in Gross Profit compared to the prior fiscal year.
- SkinHealth Systems Inc. reported Shares Outstanding of 127.52 million shares for fiscal year 2025.
- SkinHealth Systems Inc. showed an increase of +2.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: